News

Redi Health secures $14M for healthcare management platform

Ohio-based Redi Health, a tech-enabled health management platform for patients and healthcare providers, announced it closed a $14 million Series B funding round led by Blue Heron Capital. 

North Coast Ventures participated in the round alongside existing investors Mutual Capital Partners, Rev1 Ventures, M25 and Refinery Ventures.

WHAT IT DOES

Redi Health offers a patient-facing mobile app and web platform that includes medication and symptom tracking. 

It also provides a message center and navigator tool that connects life sciences companies, care providers and other healthcare stakeholders, including specialty pharmacies, co-pay vendors, data aggregators and payors. 

“With Blue Heron Capital’s backing, we are poised to bring new products to market, expand our reach, and continue to innovate at the intersection of technology and healthcare. Our goal is to make comprehensive, patient-centered care accessible to millions more across the country,” Luke Buchanan, cofounder and CEO of Redi Health, said in a statement. 

MARKET SNAPSHOT

Redi Health scored $3.7 million in 2022.

Another health-management platform, b.well Connected Health, announced this week it closed a $40 million Series C growth round led by Leavitt Equity Partners. 

Last year, Boston-based Laudio, another company offering a care management platform, announced it secured $13 million in Series B funding, bringing its total raise to $25 million.

“Streamlining AI-Enabled Digital Health Technologies From Research to Implementation” is scheduled for Tuesday, March 12, 1:30-2:30 p.m. ET, in W304A at HIMSS24 in Orlando. Learn more and register.

Avatar

admin

About Author

You may also like

News

Senior-focused VR company MyndVR will be covered by New York insurer

VR digital therapeutic company MyndVR announced AgeWell New York’s insurance plans for Medicare and Medicaid patients would cover its senior-focused
News

GoodRx shared health data with Google and Facebook, FTC says

The Federal Trade Commission on Wednesday alleged drug-cost and telehealth platform GoodRx shared consumers’ personal health information with third parties